Shearman & Sterling advised the underwriters of Homology Medicines, Inc.’s initial public offering of 10,350,000 shares of common stock (including 1,350,000 shares purchased by the underwriters…
Homology Medicines, Inc.’s $165 Million Initial Public Offering
